GAF Healthcare
Specialty Overview

Best Hospitals for Prostate Cancer Treatment in Hyderabad, India

4 cancer care hospitals in our India network are listed in Hyderabad, accredited by JCI, NABH, with 10,076 beds combined.

4
Hospitals Listed
1
City
4.5
Avg. Rating
2
Accreditation Types
The Short Answer

This page lists the cancer care hospitals in our directory offering Prostate Cancer Treatment in Hyderabad, India, including KIMS Hospitals, Secunderabad, Yashoda Hospitals, Secunderabad, Apollo Hospital DRDO, Apollo Hospitals, Jubilee Hills. Each listing links through to the hospital's full profile page.

Including:🇮🇳 KIMS Hospitals, Secunderabad🇮🇳 Yashoda Hospitals, Secunderabad🇮🇳 Apollo Hospital DRDO

Ask us about prostate cancer treatment in Hyderabad, India

Share a few details and our care coordination team will get back to you with next steps.

Compare 4 accredited hospitals for Cancer Care in Hyderabad, India

KIMS Hospitals, Secunderabad Featured
Starting from$1,000

🇮🇳 KIMS Hospitals, Secunderabad

Hyderabad, India 4.8 (743 reviews) 8,300 beds
Why consider this hospital?
4.8/5 rating from 743 reviewsAccredited by JCI, NABH8,300 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsNephrology
Accredited by JCI, NABH

Patients considering prostate cancer treatment can be cared for by KIMS Hospitals, Secunderabad's care team in Hyderabad, India, from initial consultation through recovery. KIMS Hospitals, Secunderabad, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing prostate cancer treatment.

4.8/5
Rating
2000
Established
8,300
Beds
Hyderabad, India
Location
Enquire NowView Profile
Yashoda Hospitals, Secunderabad
Starting from$1,000

🇮🇳 Yashoda Hospitals, Secunderabad

Secunderabad, Hyderabad, India 4.7 (518 reviews) 1,026 beds
Why consider this hospital?
4.7/5 rating from 518 reviewsAccredited by NABH1,026 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyNeurologyOrthopedicsOncologyGastroenterology
Accredited by NABH

Patients considering prostate cancer treatment can be cared for by Yashoda Hospitals, Secunderabad's care team in Secunderabad, Hyderabad, India, from initial consultation through recovery. Yashoda Hospitals, Secunderabad, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing prostate cancer treatment.

4.7/5
Rating
1989
Established
1,026
Beds
Secunderabad, Hyderabad, India
Location
Enquire NowView Profile
Apollo Hospital DRDO
Starting from$1,000

🇮🇳 Apollo Hospital DRDO

Kanchan Bagh, Hyderabad, India 4.5 (82 reviews) 200 beds
Why consider this hospital?
4.5/5 rating from 82 reviewsAccredited by NABH, JCI200 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsOncologyNeurosciencesTransplant
Accredited by NABH, JCI

Patients considering prostate cancer treatment can be cared for by Apollo Hospital DRDO's care team in Kanchan Bagh, Hyderabad, India, from initial consultation through recovery. Apollo Hospital DRDO, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing prostate cancer treatment.

4.5/5
Rating
2001
Established
200
Beds
Kanchan Bagh, Hyderabad, India
Location
Enquire NowView Profile
Apollo Hospitals, Jubilee Hills
Starting from$1,000

🇮🇳 Apollo Hospitals, Jubilee Hills

Hyderabad, India 4.1 (44 reviews) 550 beds
Why consider this hospital?
4.1/5 rating from 44 reviewsAccredited by JCI, NABH550 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering prostate cancer treatment can be cared for by Apollo Hospitals, Jubilee Hills's care team in Hyderabad, India, from initial consultation through recovery. Apollo Hospitals, Jubilee Hills, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing prostate cancer treatment.

4.1/5
Rating
1988
Established
550
Beds
Hyderabad, India
Location
Enquire NowView Profile
Our Methodology

How we selected these hospitals

A hospital appears on this page when Cancer Care is among its listed specialties and it is located in Hyderabad, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Prostate Cancer Treatment in Hyderabad, India?

Choosing the right hospital for prostate cancer treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include cancer care rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Prostate Cancer Treatment

Prostate cancer treatment encompasses a spectrum of precision oncology interventions—from robotic-assisted radical prostatectomy and intensity-modulated radiotherapy (IMRT) to hormonal therapy, brachytherapy, and novel androgen receptor pathway inhibitors—achieving 5-year survival rates exceeding 95% for localized disease and 70–80% for locally advanced stages when managed at high-volume centers.

3–7 days (varies by modality: robotic prostatectomy typically 2–3 days; radiotherapy is outpatient over 4–8 weeks)
Hospital Stay
2–6 weeks (post-surgery fit-to-fly is typically 3–4 weeks; radiotherapy patients may fly within 1–2 weeks of completing treatment, subject to oncologist clearance)
Total Stay in Country (Fit-to-Fly)
95%+ (localized disease, 5-year relative survival); 70–80% (locally advanced/metastatic, with modern systemic therapy)
Success Rate

Clinical Overview

  • Prostate cancer arises from the malignant transformation of glandular epithelial cells in the prostate, a walnut-sized exocrine gland situated inferior to the bladder and anterior to the rectum.
  • It is the second most common cancer in men globally, with adenocarcinoma accounting for over 95% of cases.
  • Disease behavior ranges from indolent, low-risk tumors that may be managed with active surveillance to aggressive, high-grade cancers that require multimodal systemic intervention.
Full details →

Who is a Candidate?

  • Men diagnosed with prostate adenocarcinoma confirmed by transrectal ultrasound (TRUS)-guided biopsy or MRI-fusion targeted biopsy, with pathology graded using the Gleason/Grade Group system
  • Localized disease (T1–T2, N0, M0) candidates for curative intent: robotic-assisted radical prostatectomy (RARP), external beam radiotherapy (EBRT/IMRT/VMAT), or low-dose-rate (LDR) brachytherapy
  • Locally advanced disease (T3–T4, N1, M0) candidates for combined modality: EBRT + long-term ADT, with or without docetaxel intensification per STAMPEDE trial data
  • Metastatic castration-sensitive prostate cancer (mCSPC) patients eligible for ADT + novel hormonal agents (abiraterone + prednisone, enzalutamide, apalutamide) or ADT + docetaxel chemotherapy
  • +4 more

Treatment Options & Approaches

  • ACTIVE SURVEILLANCE

Recovery

  • STEP 1 — PRE-ARRIVAL CONSULTATION (Week 1–2, Remote) Patients share existing diagnostic reports (PSA, biopsy pathology, MRI, CT/bone scan) with GAF Healthcare's clinical coordinators.
  • A virtual consultation is arranged with the treating uro-oncologist and/or radiation oncologist within 48–72 hours.
  • The multidisciplinary tumor board reviews the case and provides a preliminary treatment plan with cost estimate before the patient books travel.

Risks to be aware of

  • Prostate cancer treatment, while highly effective, carries modality-specific risks that patients must understand before committing to a therapeutic pathway.
  • Robotic-assisted radical prostatectomy (RARP) carries risks of urinary incontinence (stress incontinence in 5–20% at 12 months, with most recovering continence by 18–24 months), erectile dysfunction (rates vary from 20–70% depending on nerve-sparing extent and pre-operative function), anastomotic leak, lymphocele formation following pelvic lymph node dissection, thromboembolic events (DVT/PE, mitigated by early ambulation and LMWH prophylaxis), and a <1% risk of intraoperative vascular or rectal injury.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides comprehensive non-medical support to ensure that international patients and their accompanying family members experience a seamless, stress-free journey from their home country to India or the UAE and back.

Cost Range for Related Procedures

Cancer Surgery$4,000–$15,000
Chemotherapy$1,000–$4,000
Radiation Therapy$3,500–$10,000
Get a personalised estimate with our cost calculator →

Common questions about Prostate Cancer Treatment

What is the cost of Prostate Cancer Treatment in India versus the UAE?
The cost of prostate cancer treatment varies significantly by modality, stage, and destination. In India, a complete treatment course—whether robotic-assisted radical prostatectomy (RARP), a full IMRT/SBRT radiotherapy program, or initiation of systemic hormonal therapy—typically ranges from $4,000 to $18,000 USD. This includes hospital admission, surgery or radiotherapy sessions, anesthesia (where applicable), standard investigations, and nursing care at JCI- and NABH-accredited hospitals. In the UAE (Dubai or Abu Dhabi), equivalent treatment at JCI- and DHA-accredited facilities ranges from $12,000 to $45,000 USD, reflecting premium infrastructure, Western-trained specialist density, and luxury patient accommodation standards. India is generally 50–70% more cost-effective than the UAE for oncological procedures. However, drug costs for advanced systemic therapies (e.g., enzalutamide, abiraterone, Lutetium-177 PSMA-617) are calculated separately and depend on the regimen and treatment duration. GAF Healthcare provides fully itemized cost estimates before the patient travels, ensuring financial transparency with no hidden fees.
How long do I need to stay in the country before I am fit to fly home after Prostate Cancer Treatment?
The duration of in-country stay before you are medically cleared to fly home depends on the treatment modality selected. After robotic-assisted radical prostatectomy (RARP), patients are typically hospitalized for 2–3 days. Post-discharge recovery, urinary catheter management, and initial pathology review require an additional 2–3 weeks in-country, making the total recommended stay approximately 3–4 weeks before your oncologist issues a fit-to-fly certificate. For post-surgical patients on long-haul flights (over 6 hours), DVT prophylaxis (compression stockings and, if indicated, low-molecular-weight heparin) is mandatory. For patients undergoing stereotactic body radiotherapy (SBRT/CyberKnife), treatment is completed in 5 fractions over approximately 10–14 days, and patients are generally fit to fly within 1–2 weeks of treatment completion. Conventional IMRT requires a longer in-country stay of 6–8 weeks for the full treatment course. Patients initiating systemic therapy (ADT, oral ARSIs such as enzalutamide or apalutamide, or a first cycle of docetaxel chemotherapy) require 5–10 days for initiation, safety monitoring, and prescription coordination before departure. Your GAF Healthcare clinical coordinator will confirm the exact fit-to-fly timeline with your treating oncologist prior to discharge.
What is the success rate of Prostate Cancer Treatment at GAF Healthcare partner hospitals?
Prostate cancer has one of the highest survival rates of any cancer when detected and treated at appropriate stages. For localized prostate cancer (confined to the gland, T1–T2, N0, M0), the 5-year relative survival rate is over 99%, and the 10-year survival rate exceeds 95% with curative-intent treatment (radical prostatectomy or definitive radiotherapy). For locally advanced prostate cancer (T3–T4 or N1), 5-year survival rates range from 70–90% with combined modality treatment (EBRT + long-term ADT ± docetaxel intensification). For metastatic castration-sensitive prostate cancer (mCSPC) treated with modern doublet or triplet regimens (ADT + abiraterone, or ADT + enzalutamide), median overall survival now exceeds 5–6 years in many trial datasets (TITAN, ARCHES, ENZAMET, PEACE-1 trials). For metastatic castration-resistant prostate cancer (mCRPC), Lutetium-177 PSMA radioligand therapy (VISION trial) reduced the risk of death by 38% versus standard care. GAF Healthcare's partner hospitals are high-volume oncology centers—handling hundreds of prostate cancer cases annually—with outcomes benchmarked against international standards from institutions such as the Memorial Sloan Kettering Cancer Center and the European Institute of Oncology. Biochemical recurrence-free survival and continence/potency recovery rates at these centers are comparable to leading global cancer institutions.

Related pages

How GAF Healthcare Assists in Choosing the Best Hospital for Prostate Cancer Treatment in Hyderabad, India

Discover the Top Hospitals for Prostate Cancer Treatment in Hyderabad, India

This page lists 4 accredited cancer care hospitals in Hyderabad, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about prostate cancer treatment in Hyderabad, India

How many cancer care hospitals are listed in Hyderabad, India?
4 hospitals in our Hyderabad, India directory are currently listed for cancer care including Prostate Cancer Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Cancer Care is among its listed specialties and it is located in Hyderabad, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there cancer care hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for prostate cancer treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about prostate cancer treatment in Hyderabad, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for prostate cancer treatment in Hyderabad, India.

Contact us to report an inaccuracy on this page.

WhatsApp Us